RMANF - Roadman Investments Appoints Pharma-based Executive Shawn Moniz to Board of Directors
(TheNewswire)
VANCOUVER, British Columbia – TheNewswire - December 7, 2020 -Roadman Investments Corp. (TSXV:LITT) (FWB:1QD) (OTC:RMANF)(" RoadmanInvestments '' or the " Company ") aCanadian Venture Capital and Advisory Firm, is pleased to announcethat Shawn Moniz has been appointed to the Company’s Board ofDirectors effective immediately.
Luke Montaine, CEO of Roadman Investments commented,"We are excited to have Shawn Moniz join our Board of Directors,and look forward to integrating his deep knowledge of thepharmaceutical industry into our Company. His extensive knowledge ofthe US and Canadian pharmaceutical space in regards to marketingstrategies, product development and consumer behavioural analysis willgo a long way in adding value to our initiatives for 2021 andbeyond.”
Shawn Moniz commented, “I’m very pleased and excited to havejoined the team at Roadman Investments, and I am especially lookingforward to working with the Clov BioPharma team. I see greatuntapped potential in this company's ability to productize its CedarLeaf Oil into the mass production wheel of sanitation products fortoday's clean conscience consumer. I look forward to leveraging myexperience in working with Dr James Hudson, and the larger team atRoadman”.
Shawn Moniz
Shawn is currently the CEO of Plant & Co. Brands Inc ., a public companytrading on the Canadian Securities Exchange (“CSE”) under thesymbol: VEGN. Shawn also sits on various technology advisory boards ashe continues to be involved in entrepreneur-based initiatives spanningvarious verticals, pharmaceutical included.
Shawn has worked with the Pharma industry for over 20years, most recently with Klick Health, Canada Largest Health SciencesAgency. In his career, Shawn has worked with almost every majorplayer in the Canada and US pharmaceutical Markets developing andstrategizing multi-million dollar consumer programs. Most notably,his career client list includes AstraZeneca, Pfizer, Astellas, Takeda,Navartis, Nova nordisk, Edna, UCB, Shire, Merk, Baxter, and Sanofi.
During his tenure in thepharmaceutical vertical Shawn has helped develop countless productstrategies, customer journey programs, media-driven allocationstrategies including PPC, DTC and Veeva support programs for Canadianas well as American companies. These programs spanned over 23disease states, including biological treatment applications oftemperature-sensitive vaccines.
Shawn worked with his clients to develop monetization models foraccount groups and individual brands. The evolution of these modelsare still used by some companies today. Shawn will be looking todevelop and implement such models with the BioPharma and Roadman teamsand work hand in hand with the monetization focus of the company forthis upcoming quarter, and upcoming fiscal year of planning.
In addition, the Company also announces that it will beconducting a private placement financing for gross proceeds of up to$300,000 through the issuance of up to 10,000,000 shares(“Shares”) at a price of $0.03 per Share.
The securities being offered under the privateplacement have not been, nor will they be, registered under the UnitedStates Securities Act of 1933, as amended, and may not be offered orsold in the United States or to, or for the account or benefit of,U.S. persons absent registration or an applicable exemption from theregistration requirements. This press release shall not constitute anoffer to sell or the solicitation of an offer to buy nor shall therebe any sale of the securities in any State in which such offer,solicitation or sale would be unlawful.
About RoadmanInvestments
Roadman Investments is a Canadian Venture Capital andAdvisory Firm that strives to actively drive innovation and accelerategrowth within its portfolio holdings. Roadman looks for companiesand investments that offer breakthrough products, devices, treatmentsand health supplements with a focus on health and wellness.
Luke Montaine
CEO, Director
Roadman Investments Corp.
Luke@roadmancorp.com
Neither the TSX Venture Exchange norits Regulation Services Provider (as that term is defined in thepolicies of the TSX Venture Exchange) accepts responsibility for theadequacy or accuracy of this release.
This press release contains "forward-lookingstatements" within the meaning of applicable securities laws.Forward-looking statements can be identified by any statements thatexpress or involve discussions with respect to predictions,expectations, beliefs, plans, projections, objectives, assumptions orfuture events or performance (often, but not always, using words orphrases such as "expects" or "does not expect","is expected", "anticipates" or "does notanticipate", "plans", "estimates" or"intends", or stating that certain actions, events orresults "may", "could", "would","might" or "will" be taken, occur or be achieved),and variations of such words, and similar expressions are notstatements of historical fact and may be forward-looking statements.Examples of forward-looking statements include, among others,statements we make about the Company, its subsidiaries or otherCompany's that the Company has invested in or is otherwise affiliatedwith, regarding planned research and development activities, financingarrangements, investment strategies, returns on investments,contractual obligations including but not limited to obligations topurchase materials or meet sales milestones,strategy for customerretention, growth, product development, market position, financialresults and reserves, other statements relating to the financial andbusiness prospects, management's ability it identify and evaluateinvestments, management's ability to obtain the necessary funding orobtain the necessary licenses and approvals to operate, specifically,the necessary licenses and approvals to open any such facilities inCalifornia or the United States of America.
Forward-looking statements are neither historical factsnor assurances of future performance. Instead, they are based only onour current beliefs, expectations and assumptions regarding the futureof our business, future plans and strategies, projections, anticipatedevents and trends, the economy and other future conditions. Becauseforward-looking statements relate to the future, they are subject toinherent uncertainties, risks and changes in circumstances that are difficult to predict and many of whichare outside of our control. Our actual results and financial conditionmay differ materially from those indicated in the forward-lookingstatements. Therefore, you should not rely on any of theseforward-looking statements. Important factors that could cause ouractual results and financial condition to differ materially from thoseindicated in the forward-looking statements include, among others, thefollowing: economic and financial conditions, including volatility ininterest and exchange rates, commodity and equity prices and the valueof financial assets, continued volatility in the capital or creditmarkets the adequacy of our cash flow to fund the operations of theCompany or its affiliates, strategic actions, including acquisitionsand dispositions and our success in evaluating acquired businesses andour success in developing the businesses underlying theseacquisitions, the occurrence of hostilities, political instability orcatastrophic events, changes in customer demand, the extent to whichwe are successful in gaining new long-term relationships withcustomers or retaining existing ones and the level of service failuresthat could lead customers to use competitors' services, developmentsand changes in laws and regulations, including increased regulation ofthe medical, health and wellness industries through legislative actionand revised rules and standards applied by the international medical,pharmaceutical, health and wellness regulatory bodies, changes in theprice of inventory and other key materials and disruptions in supplychains for these materials, closures or slowdowns and changes incontracted service provider costs and labor difficulties, includingstoppages affecting either our operations or our service providersabilities to conduct research and develop and produce products,management's ability to operate our business models, availability offinancing to provide sufficient working capital maintain the businessas a going concern, availability of financing to fund the Company's orit is subsidiaries business operations, including but not limited to,meeting the Company's obligations under the agreement with Psychedelicinsights, compliance and approvals under the appropriate State andFederal laws and other factors as discussed in the Company's filingswith Canadian securities regulators, which are available at www.sedar.com .
Investors are cautioned that forward-looking statementsare not guarantees of future performance or events and, accordinglyare cautioned not to put undue reliance on forward-looking statementsdue to the inherent uncertainty of such statements. Theforward-looking statements included in this news release are made asof the date hereof and the Company disclaims any intention orobligation to update or revise any forward-looking statements, whetheras a result of new information, future events or otherwise, except asexpressly required by applicable securities legislation. This news isnot for dissemination in the United States of America.
Copyright (c) 2020 TheNewswire - All rights reserved.